ASC-69
PD-1/PD-L1-IN-29 intermediate-2
Erfonrilimab
Retifanlimab
Zeluvalimab
Reozalimab
Sudubrilimab
Peresolimab
Rosnilimab
Pucotenlimab
Emfizatamab
Cosibelimab
Sasanlimab
Pimivalimab
Opucolimab
Prolgolimab
Nofazinlimab
Pacmilimab
Rulonilimab
Socazolimab